Neuropathology and Applied Neurobiology,
Journal Year:
2017,
Volume and Issue:
44(1), P. 91 - 111
Published: Oct. 4, 2017
Accumulating
evidence
indicates
an
important
pathophysiological
role
of
brain
inflammation
in
epilepsy.
In
this
review,
we
will
provide
update
specific
inflammatory
pathways
that
have
been
proposed
to
be
crucial
the
underlying
molecular
mechanisms
epilepsy,
including
interleukin-1
receptor/toll-like
receptor
signalling,
cyclooxygenase-2,
tumour
necrosis
factor-alpha,
complement
signalling
and
chemokines.
Furthermore,
by
drawing
on
from
preclinical
clinical
studies
discuss
potential
these
targets
for
novel
therapeutic
interventions
control
drug-resistant
seizures
or
disease-modifying
effects.
Finally,
assess
use
as
biomarkers
development
epilepsy
measure
effectiveness
interventions.
Gut,
Journal Year:
2018,
Volume and Issue:
68(5), P. 829 - 843
Published: Dec. 15, 2018
Objective
Recent
evidence
suggesting
an
important
role
of
gut-derived
inflammation
in
brain
disorders
has
opened
up
new
directions
to
explore
the
possible
gut-brain
axis
neurodegenerative
diseases.
Given
prominence
dysbiosis
and
colonic
dysfunction
patients
with
Parkinson’s
disease
(PD),
we
propose
that
toll-like
receptor
4
(TLR4)-mediated
intestinal
could
contribute
central
PD-related
neurodegeneration.
Design
To
test
this
hypothesis
performed
studies
both
human
tissue
a
murine
model
PD.
Inflammation,
immune
activation
microbiota
composition
were
measured
samples
from
subjects
PD
healthy
controls
rotenone
or
vehicle-treated
mice.
further
assess
TLR4
signalling
PD-induced
neuroinflammation,
used
TLR4-knockout
(KO)
mice
conjunction
oral
administration
Results
Patients
have
barrier
disruption,
enhanced
markers
microbial
translocation
higher
pro-inflammatory
gene
profiles
biopsy
compared
controls.
In
regard,
found
increased
expression
bacterial
endotoxin-specific
ligand
TLR4,
CD3+
T
cells,
cytokine
biopsies,
characterised
by
decrease
abundance
SCFA-producing
bacteria
Rotenone
treatment
TLR4-KO
revealed
less
inflammation,
motor
dysfunction,
neuroinflammation
neurodegeneration,
relative
rotenone-treated
wild-type
animals
despite
presence
dysbiotic
Conclusion
Taken
together,
these
suggest
TLR4-mediated
plays
and/or
which
may
be
one
key
factors
leading
neurodegeneration
Brain,
Journal Year:
2015,
Volume and Issue:
138(5), P. 1138 - 1159
Published: March 29, 2015
The
emerging
roles
of
microglia
are
currently
being
investigated
in
the
healthy
and
diseased
brain
with
a
growing
interest
their
diverse
functions.
In
recent
years,
it
has
been
demonstrated
that
not
only
immunocentric,
but
also
neurobiological
can
impact
neural
development
maintenance
neuronal
cell
function
both
pathological
contexts.
disease
context,
there
is
widespread
consensus
dynamic
cells
potential
to
contribute
central
nervous
system
damage
repair.
Indeed,
number
studies
have
found
microenvironmental
conditions
selectively
modify
unique
phenotypes
One
novel
mechanism
garnered
involves
regulation
microglial
by
microRNAs,
which
therapeutic
implications
such
as
enhancing
microglia-mediated
suppression
injury
promoting
repair
following
inflammatory
injury.
Furthermore,
recently
published
articles
identified
molecular
signatures
myeloid
cells,
suggesting
distinct
population
compared
other
lineage
access
under
conditions.
Thus,
new
opportunities
exist
help
distinguish
permit
study
functions
health
disease.
Endocrine Reviews,
Journal Year:
2016,
Volume and Issue:
37(4), P. 372 - 402
Published: May 19, 2016
Inflammatory
activation
of
microglia
is
a
hallmark
several
disorders
the
central
nervous
system.
In
addition
to
protecting
brain
against
inflammatory
insults,
are
neuroprotective
and
play
significant
role
in
maintaining
neuronal
connectivity,
but
prolongation
an
status
may
limit
beneficial
functions
these
immune
cells.
The
finding
that
estrogen
receptors
present
monocyte-derived
cells
estrogens
prevent
control
response
raise
question
this
sex
steroid
plays
manifestation
progression
pathologies
have
clear
difference
prevalence,
such
as
multiple
sclerosis,
Parkinson's
disease,
Alzheimer's
disease.
review
aims
provide
critical
current
literature
on
actions
involvement
selected
neurological
disorders.
This
understanding
highlights
research
area
should
be
expanded
identify
appropriate
replacement
therapies
slow
diseases.
Neurobiology of Disease,
Journal Year:
2018,
Volume and Issue:
135, P. 104352 - 104352
Published: Dec. 20, 2018
Recent
evidence
provides
support
for
involvement
of
the
microbiota-gut-brain
axis
in
Parkinson's
disease
(PD)
pathogenesis.
We
propose
that
a
pro-inflammatory
intestinal
milieu,
due
to
hyper-permeability
and/or
microbial
dysbiosis,
initiates
or
exacerbates
PD
One
factor
can
cause
and
dysbiosis
is
chronic
stress
which
has
been
shown
accelerate
neuronal
degeneration
motor
deficits
Parkinsonism
rodent
models.
hypothesized
stress-induced
barrier
dysfunction
lead
milieu
phenotype
low-dose
oral
rotenone
mice
model.
To
test
this
hypothesis,
received
unpredictable
restraint
(RS)
12
weeks,
during
last
six
weeks
also
daily
administration
(10
mg/kg/day)
orally.
The
initial
RS
caused
significantly
higher
urinary
cortisol,
hyperpermeability,
decreased
abundance
putative
"anti-inflammatory"
bacteria
(Lactobacillus)
compared
non-stressed
mice.
Rotenone
alone
(i.e.,
without
RS)
disrupted
colonic
expression
tight
junction
protein
ZO-1,
increased
oxidative
(N-tyrosine),
myenteric
plexus
enteric
glial
cell
GFAP
α-synuclein
(α-syn)
levels
colon
controls.
Restraint
exacerbated
these
rotenone-induced
changes.
Specifically,
potentiated
effects
including:
1)
hyper-permeability,
2)
disruption
proteins
(ZO-1,
Occludin,
Claudin1),
3)
4)
inflammation
cells
(GFAP
+
glia
cells),
5)
α-syn,
6)
relative
fecal
Akkermansia
(mucin-degrading
Gram-negative
bacteria),
7)
endotoxemia.
In
addition,
promoted
number
brain
reduced
resting
microglia
dystrophic/phagocytic
as
well
(FJ-C+)
dying
substantia
nigra
(SN),
lipopolysaccharide
(LPS)
reactivity
SN,
dopamine
(DA)
DA
metabolites
(DOPAC,
HVA)
striatum
control
Our
findings
model
stress-induced,
gut-derived,
via
dysfunctional
axis.